OPKO Health
OPK
#5848
Rank
ยฃ0.79 B
Marketcap
ยฃ1.00
Share price
-1.47%
Change (1 day)
-18.93%
Change (1 year)

P/E ratio for OPKO Health (OPK)

P/E ratio as of December 2025 (TTM): -5.67

According to OPKO Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.66667. At the end of 2024 the company had a P/E ratio of -21.0.

P/E ratio history for OPKO Health from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-21.0247.68%
2023-6.04112.61%
2022-2.84-97.05%
2021-96.2-221.77%
202079.0-2948.3%
2019-2.77-75.12%
2018-11.120.58%
2017-9.25-96.02%
2016-233101.42%
2015-115362.19%
2014-25.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
19.2-438.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
15.0-365.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
15.9-381.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
45.3-900.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
> 1000-81,513.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.1-400.95%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
25.2-544.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-25.2 345.01%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.